Dr. Mukesh A Patel, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1421 Lincoln Ave, Prospect Park, PA 19076 Phone: 610-532-5343 Fax: 610-532-1302 |
News Archive
The NICE guidelines on follow-up for breast cancer patients need urgent revision, warn experts in this week's BMJ.
Almost two years ago, the diabetes arm of the Heart Protection Study, the largest-ever study using a cholesterol-lowering medication, found that diabetics who took a daily dose of the statin drug simvastatin over five years reduced the risk of a first nonlethal heart attack by 37 percent and risk of a first nonfatal or fatal stroke by 24 percent, regardless of their cholesterol or glucose levels.
Children and young people whose mothers had a BMI greater than 30 during early pregnancy are at an increased risk of fatty liver disease.
Neogenix Oncology, Inc. announced today that researchers at Duke University Medical Center have received approval to move forward with a Phase I trial of the company's lead therapeutic antibody, NPC-1C, in patients with advanced stage pancreatic or colorectal cancer. Duke joins Johns Hopkins Hospital which is already conducting the Phase I trial of NPC-1C. In addition to Johns Hopkins, North Shore - LIJ has also enrolled patients on this multi-center study.
› Verified 5 days ago